Visit us at L003
Innovation and integration enable QuarkBio to deliver accessible solution for customer success
Oncogenic Druggable Fusion
First line screening for possible fusion-targeted therapy
Indeterminate
Thyroid Nodule Cytology
Solution: Risk stratification through fast, affordable molecular analysis
Insight to Action
Transform your research into clinical-actionable product
NextAmp™
Analysis System
A dual-functioning system capable of multi-biomarker analysis and digital detection of low quantity genes
Innovation through Collaborations
We collaborate for your success by customizing smarter and more suitable biomarker solution to meet your clinical needs
High Tolerance for Sample Quality
Our assays enable more patients to receive suitable drug treatments with the ability to analyze poor quality and low concentration samples
Pinpoint Eligible Patients
PanelChip® offers a cost-effective platform for large scale screening of patient with rare gene rearrangements
Proven Clinical Utility with Expression Biomarkers
Translating discoveries into products, we have helped multiple companies develop mRNA- and miRNA-based assay
What We Do
Simple to use cancer panels for actionable mutations and diagnosis
ThyroSCAN
Test for patient with suspicious thyroid nodules
FusionQuest
Test for cancer druggable fusions
Customized Services
Tailored-made Cancer Panels
Why QuarkBio?
Latest News
Events
Healthcare Expo | Taiwan
Healthcare Expo | Taiwan
CONFERENCE
Exhibition: Sep 01 – 04, 2022
Location: Taipei Nangang Exhibition Center, Hall 1, 1、4F (L003)
MEDICA 2022 | Düsseldorf, Germany
MEDICA 2022 | Düsseldorf, Germany
CONFERENCE
Exhibition: Nov 14 – 17, 2022
Location: D-40474 Düsseldorf, Am Staad (Stockumer Höfe)
Publications
Learn more
